C-Suite Perspectives

Precision Oncology in Australia: insights from Prof David Thomas

In partnership with industry and government, Omico launched the pioneering initiative PrOSPeCT in July 2023, aimed at integrating comprehensive genomic profiling (CGP) into standard oncology care in Australia. To date, Omico has provided CGP to over 15,000 patients, of whom more than 1,600 have received matched therapies primarily through accelerated access to clinical trials. Professor […]

Precision Oncology in Australia: insights from Prof David Thomas Read More »

Changi General Hospital’s CEO discusses SMART hospitals and healthcare systems at RED 2024

Changi General Hospital (CGH) through the Office of Innovation, Centre for Healthcare & Assistive Robotic Technology and AI & Data Office has embarked on a generative AI journey using real-time big data, analytics, predictive algorithms and automation, melding man with technology to improve healthcare delivery and to future-proof an ageing workforce. CGH’s CEO, Clinical Professor

Changi General Hospital’s CEO discusses SMART hospitals and healthcare systems at RED 2024 Read More »

Building bridges: connecting with customers in the new era of laboratory diagnostics

The global landscape of laboratory diagnostics is undergoing a rapid transformation, driven by the emergence of new devices, business models, and a growing focus on patient-centricity. This presentation by Ms Daria Goryakina, Co-Founder & Managing Partner of HELIX Group, explores the evolving landscape of laboratory diagnostics and its business models, highlighting key trends and innovations.

Building bridges: connecting with customers in the new era of laboratory diagnostics Read More »

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem

In early 2023, The Mayo Clinic restructured its laboratory operations to enable the vision of a connected, interoperable, global diagnostics ecosystem. Dr William Morice II, CEO of Mayo Collaboratives Services, will share why this ecosystem is critical for patients and how the team is overcoming barriers. Now available with Korean subtitles.

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem Read More »

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty 

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty 

When she first joined PT Prodia over 20 years ago, now President Director Dr Dewi Muliaty reflects on how the company has grown from a small collection of 9 branches to one of the largest commercial laboratory groups in Indonesia. In this interview with Mr Lee Poh Seng, Director, Diagnostics Division, PT Roche Indonesia, they

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty  Read More »

Advancing diagnostics in Pakistan with total lab automation: Q&A with Dr Rizwan Uppal

Advancing diagnostics in Pakistan with total lab automation Q&A with Dr Rizwan Uppal_thumbnail

As one of the largest providers of diagnostic services in Pakistan, Islamabad Diagnostics Centre (IDC) performs more than 7 million tests annually across 130 branches in the country. Chairman, Founder & CEO, Dr Rizwan Uppal sits down with Mr Abdul Qayyum, Country Manager of Roche Diagnostics Pakistan, and talks about the establishment of the IDC

Advancing diagnostics in Pakistan with total lab automation: Q&A with Dr Rizwan Uppal Read More »

Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)

How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)

As CEO of Awanui Group, Anoop Singh looks after one of the most important institutions in New Zealand’s laboratory medicine ecosystem. In this Q&A with Wing Lam Wong, General Manager of Roche Diagnostics New Zealand, Singh introduces his organisation and discusses how partnerships with IVD suppliers, community groups, governmental entities and other key stakeholders are

Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1) Read More »

Mass spectrometry for routine clinical testing: Q&A with Prof Junghan Song

The power of clinical mass spectrometry: Q&A with Prof Junghan Song

As President & CEO of Seoul National University Bundang Hospital (SNUBH), Prof Junghan Song leads one of Korea’s most important healthcare institutions. His scope of responsibility includes oversight of the SNUBH lab, which currently uses mass spectrometry for routine clinical testing, including drug analysis, toxicology assessment, biochemical genetics testing, analysis of diverse metabolites, and some

Mass spectrometry for routine clinical testing: Q&A with Prof Junghan Song Read More »

Scroll to Top